Clinical Differences in Triple-Positive Operable Breast Cancer Subtypes in Korean Patients: An Analysis of Korean Breast Cancer Registry Data

PURPOSE: Triple-positive breast cancer is defined by estrogen receptor, progesterone receptor, and human epidermal growth factor receptor 2 (HER2) positivity. Several systemic breast cancer therapies target hormonal and HER2 responsiveness. We compared clinical outcomes of triple-positive disease wi...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:J Breast Cancer
Hlavní autoři: You, Sun Hyong, Chae, Byung Joo, Eom, Yong Hwa, Yoo, Tae-Kyung, Kim, Yong-seok, Kim, Jeong Soo, Park, Woo-Chan
Médium: Artigo
Jazyk:Inglês
Vydáno: Korean Breast Cancer Society 2018
Témata:
Original Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC6310716/
https://ncbi.nlm.nih.gov/pubmed/30607163
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4048/jbc.2018.21.e53
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky